Moneycontrol PRO
HomeNewsIndia market

India Market

Jump to
  • China outpaces India amid emerging market turmoil; valuation gap hits record $6.3 trillion

    According to data from Bloomberg, the MSCI India Index has lagged its Chinese counterpart by nearly 10 percentage points this quarter, marking India’s worst relative annual performance since 2017. Currently, the MSCI India trades at more than 21 times its one-year forward earnings, compared to just 11.9 times for China.

  • Fintech startup Easebuzz doubles revenue to Rs 236 crore in FY23 as demand surges

    Since the end of last year, Easebuzz has witnessed jump in its services after the RBI directed some of its competitors like Razorpay, and Cashfree to pause on-boarding new merchants

  • Taking a down round is not a big deal, startups have to move on: General Catalyst’s CEO Hemant Taneja

    According to Hemant Taneja, the VC firm plans to invest 10-20% of the 11th General Fund, which has a total amount of approximately $4.6 billion, in India.

  • Four standout takeaways for the stock market from FY22

    During the year, the country faced numerous macroeconomic and geopolitical challenges. Considering the circumstances, the Indian stock market did extremely well in FY22

  • Mastercard rolls out new tech to replace OTP step for online transactions: Report

    For transactions below Rs 2,000, the new solution provides sellers with customer details automatically after the first purchase, while for those above Rs 2,000 users can create a unique transaction PIN

  • Wall Street could well correct by up to 10% in near term: Geoff Lewis

    On the back of strong macroeconomic data, a correction is overdue but relatively mild. It would not extend to 15-20 percent. The maximum downside is around 10 percent,” he said.

  • Sensex may break 25k at open; oil slump, Fed in focus

    A sharp slump in the oil market, Federal Reserve's meeting this week and a junk bond market selloff is in focus.

  • Merck drops India from Priority market list

    US pharma major Merck (MSD) dropped India from its list of priority markets. Other top multinational pharma companies have also sounded warning bells about India's IPR regime.

  • Nomura is bearish on India, feels inflation may worsen

    Crude oil prices have been ruling markets globally, but foreign institutional investors continue to cold shoulder emerging economies, including India. Ian Scott global head of equity strategy with Nomura says he prefers developed markets to emerging ones.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347